Skip to main content

PROTECTING THE LIVES OF MOTHERS AND CHILDREN

Pioneers in the early detection of gestational diseases

Our vision is a world where pregnant women do not fear for their health

Latest technologies used by Ipremom

ABOUT US

Our research brings new opportunities to safeguard maternal health throughout pregnancy

iPremom is a pioneering company that develops molecular blood tests to monitor health during pregnancy using the latest technologies

We work to protect the lives of mothers and their children through the early prediction of pregnancy complications, such as preeclampsia

SCIENTIFIC BACKGROUND

Our landmark research into uterine function has improved our understanding of the defects promoting pregnancy complications

pink uterus drawing
Uterine dysfunction Pregnancy establishment PE symptoms Delivery

OUR GOAL

The early prediction and prevention of preeclampsia

PREMOM CLINICAL STUDY

We aim to provide solutions for the early detection and prevention of pregnancy diseases

We have conducted a prospective study to evaluate the diagnostic precision of a molecular test to detect preeclampsia risk before symptoms appear

Our study provides invaluable insights into the early detection and prevention of preeclampsia and other diseases through the analysis of thousands of circulating molecules in maternal blood

PREMOM clinical study

Our prospective clinical study has been completed, providing support for the early detection of pregnancy-related diseases before symptoms appear

14

Participating hospitals

26,000

Samples collected

9,600

Pregnant women recruited

100

of the women enrollment achieved

PREECLAMPSIA SCREENING TEST

Our research focuses on the development of a straightforward blood test that predicts pregnancy complications through the detection of circulating RNA molecules

Ipremom's screening test creativity

14

HOSPITALS COLLABORATE WITH US